Expert Session: Future of Minimal Residual Disease

This site is a non-promotional medical portal for UK Healthcare Professionals

Not a healthcare professional? Visit our Public site

For UK Healthcare Professionals

This site is a non-promotional medical portal for UK Healthcare Professionals
Not a healthcare professional? Visit our Public site

For UK Healthcare Professionals

Expert Session: Future of Minimal Residual Disease

Prof Martin Kaiser discusses the future capabilities of Minimal Residual Disease in treating Multiple Myeloma

NX-GB-MMU-VID-250004 (V1.0)

Get in touch

Contact us

Report adverse event
Terms of use
Privacy Notice

© 2024 GSK group of companies or its licensor. Trade marks are owned by or licensed to the GSK group of companies.
February 2026 I NX-GB-NA-WCNT-230005 (v9.0)